This HTML5 document contains 65 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n10	http://dx.doi.org/10.1093/EHJCVP/
n11	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q92058713

rdf:type

wikibase:Item

schema:description

artikull shkencor i botuar më 01 janar 2020 im Jahr 2020 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 January 2020 articolo scientifico (pubblicato il 2020) наукова стаття, опублікована 1 січня 2020 artículo científico publicado en 2020 artículu científicu espublizáu en xineru de 2020 article scientifique (publié 2020) научна статия artigo científico (publicado na 2020) wetenschappelijk artikel

p:P577

wds:Q92058713-04AF9DAA-F2E0-4D74-A656-E0C00FB5B56C

wdt:P577

2020-01-01T00:00:00Z

p:P2093

wds:Q92058713-8A19801F-01DC-4B6B-B41C-ACC3B26437BF wds:Q92058713-826EB1FF-4B08-4721-BACC-D16D7C99C934 wds:Q92058713-7D96043D-D600-4A1E-A02F-6C022F8C60C1 wds:Q92058713-CF80E0C4-005A-4F63-9170-CA23C768AA7C wds:Q92058713-C9979C8A-7244-4B8F-AE6E-B1948B9D6E69 wds:Q92058713-C8024979-9DC1-416F-8E6F-068B29B190F5 wds:Q92058713-BB80F632-A348-4375-A8F5-F935039C33F3 wds:Q92058713-3BBD30BD-7ABB-4BD4-AC67-F377C45389A4 wds:Q92058713-180A4EEC-0145-43B1-AB21-5A979C37A3AE wds:Q92058713-00DAFE88-8D83-4A64-8B8F-8AD7C874FA00

wdt:P2093

David Erlinge Rebecca Rylance Tania Sharma Ole Fröbert Sofia Karlsson Dimitrios Venetsanos Elmir Omerovic Jonas Persson Sasha Koul Stefan James

rdfs:label

Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VAL Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VAL Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VAL

skos:prefLabel

Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VAL Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VAL Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VAL

schema:name

Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VAL Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VAL Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VAL

p:P1476

wds:Q92058713-8DEEEDC2-A2BD-4805-8596-C110BB4DA729

wdt:P1476

Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VALIDATE-SWEDEHEART substudy

p:P304

wds:Q92058713-8B48E5F0-9E51-4028-A64F-54BF26C44B29

wdt:P304

6-13

p:P31

wds:Q92058713-AC0AE3F3-E262-4849-B51E-9F7B1F0DC241

wdt:P31

wd:Q13442814

p:P921

wds:Q92058713-8944C7E2-F28B-4729-B5CF-1DB69CA8BD50 wds:Q92058713-02595D42-2B0C-4FD2-B58F-954A644360D9

wdt:P921

wd:Q63279445 wd:Q18558122

p:P698

wds:Q92058713-9D1F00D1-C5A6-4791-B411-C8F40F41DF4F

wdtn:P698

n11:31093662

wdt:P698

31093662

p:P1433

wds:Q92058713-12659986-FC26-4937-8597-287AB01B2104

wdt:P1433

wd:Q27726932

p:P433

wds:Q92058713-9BC4B163-EEAA-4D8E-94C2-AC6ABCADCE32

p:P478

wds:Q92058713-91608F97-B5F9-46E7-A06E-3E5AECA1809C

wdt:P433

1

wdt:P478

6

p:P356

wds:Q92058713-9A0452F7-EFBD-4143-8830-791521F8B52B

wdtn:P356

n10:PVZ015

wdt:P356

10.1093/EHJCVP/PVZ015